Analyze inflammatory markers and islet graft function through blood samples collected from subjects with chronic pancreatitis who undergo total pancreatectomy with auto islet transplantation.
A total of 100 subjects will be enrolled in this study; 85 subjects will be enrolled from patients who are scheduled for TP-AIT and 15 subjects will be for TP alone at Baylor University Medical Center at Dallas or Baylor All Saints Medical Center at Fort Worth. The patients who are enrolled in a clinical study, named 'A phase 2/3, multicenter, randomized, double-blind, placebo-controlled, parallel assignment study to assess the efficacy and safety of reparixin in pancreatic islet auto-transplantation (REP0112, IND# 117390)', can be enrolled in this study.
Study Type
OBSERVATIONAL
Enrollment
100
Baylor University Medical Center - Sammons Outpatient Cancer Center
Dallas, Texas, United States
RECRUITINGAnalysis of graft function following autologous islet transplantation
Time frame: One year after transplant of islet cells.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.